Corporate News     17-May-21
Camlin Fine Sciences to acquires 80% stake in AlgalR NutraPharms
Camlin Fine Sciences will be acquiring 80% stake in AlgalR NutraPharms. The Company will now be executing the Investment Agreement, Share Purchase Agreement and the incidental agreements / documents with AlgalR and its promoters / other shareholders.

AlgalR provides an opportunity to the Company for expanding its footprint into the Nutraceuticals segment.

AlgalR was incorporated on 24 July 2014. It is a manufacturer of Algal Omega]3 fatty acids, particularly Docosahexaenoic acid (DHA) and Eicosapentaenoic acid (EPA) from microalgae, which are considered 100% Vegetarian. Omega]3 fatty acids play an important role in the human metabolism and has been associated with a number of health benefits. These products are manufactured in compliance with the set industrial norms, FSSAI, and ISO 22000:2005 standards using a patented technology in a state]of]the]art production system located in Southern part of India.

Previous News
  Camlin Fine Sciences allots 10,400 equity shares under ESOP
 ( Corporate News - 28-Mar-24   09:12 )
  Camlin Fine Sciences reports consolidated net loss of Rs 5.53 crore in the September 2021 quarter
 ( Results - Announcements 14-Nov-21   16:26 )
  Camlin Fine Sciences consolidated net profit declines 73.66% in the June 2022 quarter
 ( Results - Announcements 13-Aug-22   08:44 )
  Board of Camlin Fine Sciences appoints director
 ( Corporate News - 31-Mar-21   18:45 )
  Camlin Fine Sciences to conduct board meeting
 ( Corporate News - 23-Jun-20   11:26 )
  Camlin Fine Sciences reports consolidated net loss of Rs 9.83 crore in the March 2017 quarter
 ( Results - Announcements 20-May-17   17:28 )
  Camlin Fine Sciences reports consolidated net loss of Rs 4.26 crore in the March 2018 quarter
 ( Results - Announcements 24-May-18   18:07 )
  Camlin Fine Sciences to discuss results
 ( Corporate News - 03-Aug-23   14:07 )
  Camlin Fine Sciences reports standalone net profit of Rs 1.22 crore in the March 2018 quarter
 ( Results - Announcements 24-May-18   18:07 )
  Camlin Fine Sciences allots 12,750 equity shares under ESOP
 ( Corporate News - 27-Jan-21   20:59 )
  Camlin Fine Sciences update on FCCBs aggregating USD 15 mn issued to IFC
 ( Corporate News - 30-Oct-21   11:48 )
Other Stories
  Board of Delhivery approves alteration in capital clause of MoA
  05-Jul-24   19:32
  J B Chemicals & Pharmaceuticals appoints director
  05-Jul-24   19:30
  Infosys announces resignation of senior management personnel
  05-Jul-24   19:22
  JLR Q1 FY25 retail sales up 9% on YoY basis
  05-Jul-24   19:08
  Bajaj Auto launches world's first CNG motorcycle 'Freedom'
  05-Jul-24   18:59
  Agenda for board meeting of Power Grid Corporation of India
  05-Jul-24   18:46
  Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
  05-Jul-24   18:06
  Vipul to hold board meeting
  05-Jul-24   17:15
  Markobenz Ventures to convene board meeting
  05-Jul-24   17:15
  Dhanashree Electronics to declare Quarterly Result
  05-Jul-24   17:15
Back Top